Sponsor or institution
Clinical trials and research at The Affiliated Hospital of Xuzhou Medical University
As of November 12, 2026, Find a Trial lists 14 clinical trials run by The Affiliated Hospital of Xuzhou Medical University that are recruiting, in China. By phase: Phase 2 (3), Phase 1 (2), Early Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 14Clinical trials
- 1Country
Newest trials
All recruiting trials (14)
-
Orelabrutinib plus standard immunochemotherapy with or without auto-HSCT for newly diagnosed DLBCL
This study tests whether adding orelabrutinib to standard chemotherapy, with or without autologous stem cell transplantation, helps newly diagnosed DLBCL patients.
-
HN2302 for adults with refractory generalized myasthenia gravis
This open-label, single-arm trial will try HN2302 injections in adults with refractory generalized myasthenia gravis to see if the treatment is safe and reduces symptoms.
-
AT1019 injections with focused radiation and PD-1 immunotherapy for advanced solid tumors
This will test whether giving injected AT1019 together with focused radiation (SBRT) and a PD‑1 immunotherapy is safe and tolerable for adults with advanced solid tumors.
-
Tislelizumab with cyclophosphamide, mitoxantrone liposomes, chidamide, and prednisone for newly diagnosed AITL
This treatment tests whether adding the immunotherapy tislelizumab to chemotherapy (cyclophosphamide and mitoxantrone liposomes), the epigenetic drug chidamide, and prednisone helps adults newly diagnosed with angioimmunoblastic T‑cell lymphoma.
-
Anti‑CD19 CAR‑T plus a BTK inhibitor for newly diagnosed high‑risk CLL/SLL
We will try combining anti‑CD19 CAR‑T cells with a BTK inhibitor as first‑line treatment for people newly diagnosed with high‑risk CLL or SLL.
-
Tislelizumab with cyclophosphamide, mitoxantrone liposomes, chidamide, and prednisone for relapsed or refractory angioimmunoblastic T-cell lymphoma
This trial will test whether adding the immunotherapy tislelizumab to chemotherapy (cyclophosphamide and mitoxantrone liposomes) plus the epigenetic drug chidamide and prednisone helps adults with relapsed or refractory angioimmunoblastic T‑cell lymphoma.
-
Investigating the role of sTREM in outcomes after thrombectomy for stroke
This study is trying to see if certain proteins in the blood can help predict how well people recover after a procedure to remove a blood clot from their brain during a stroke.
-
Investigating how gene mutations affect diabetes susceptibility in patients
This study is testing how certain gene changes might affect the risk of developing Type 2 Diabetes in newly diagnosed patients compared to healthy individuals.
-
Research on how obesity and bariatric surgery affect the body
This study looks at how obesity affects the body and how bariatric surgery changes things for people who are obese, comparing them to healthy volunteers.
-
Investigating genetic factors affecting diabetes treatment response
This study is trying to see how genetic differences affect how well the diabetes drug exenatide works for Chinese patients with Type 2 Diabetes.
-
BGT007 injection for treating difficult digestive system tumors
This study is testing a new injection called BGT007 to see if it can safely help people with tough digestive system tumors that keep coming back or don’t respond to other treatments.
-
BGT007H cells for treating difficult digestive system cancers
This study is testing a new cell treatment called BGT007H to see if it can help people with hard-to-treat digestive system cancers feel better.
-
Using CAR-T cells to treat advanced prostate cancer
This study is testing a new type of immune cell treatment for advanced prostate cancer to see if it can help patients whose cancer isn't responding to standard treatments.
-
Using B7H3 CAR-T cells to treat advanced liver cancer
This study is testing if a new type of immune cell treatment can help people with advanced liver cancer by targeting and destroying specific cancer cells.
Quick answers
How many clinical trials run by The Affiliated Hospital of Xuzhou Medical University are recruiting right now?
14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 2, Early Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.